183 related articles for article (PubMed ID: 15693799)
21. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
Oertel S; Trappe RU; Zeidler K; Babel N; Reinke P; Hummel M; Jonas S; Papp-Vary M; Subklewe M; Dörken B; Riess H; Gärtner B
Ann Hematol; 2006 Jul; 85(7):478-84. PubMed ID: 16586109
[TBL] [Abstract][Full Text] [Related]
22. Hodgkin disease-like posttransplantation lymphoproliferative disorder of donor origin in a renal allograft recipient.
Schlieper G; Kurschat C; Donner A; Huckenbeck W; Rüdiger T; Sandmann W; Grabensee B; Ivens K; Heering P
Am J Kidney Dis; 2006 Mar; 47(3):e37-41. PubMed ID: 16490613
[TBL] [Abstract][Full Text] [Related]
23. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
Henry DD; Hunger SP; Braylan RC; Dharnidharka VR
Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
[TBL] [Abstract][Full Text] [Related]
24. Post-transplant lymphoproliferative disorders after heart or kidney transplantation at a single centre: presentation and response to treatment.
Aversa SM; Stragliotto S; Marino D; Calabrese F; Rigotti P; Marchini F; Gambino A; Feltrin G; Boso C; Canova F; Soldà C; Mazzarotto R; Burra P
Acta Haematol; 2008; 120(1):36-46. PubMed ID: 18797163
[TBL] [Abstract][Full Text] [Related]
25. EBV lymphoproliferative disease of host origin after haploidentical stem cell transplantation.
Kasow KA; Leung W; Horwitz EM; Woodard P; Handgretinger R; Hale GA
Pediatr Blood Cancer; 2007 Nov; 49(6):869-72. PubMed ID: 16421900
[TBL] [Abstract][Full Text] [Related]
26. Brain tumor as an unusual presentation of posttransplant lymphoproliferative disorder.
Azarpira N; Torabineghad S; Rakei M
Exp Clin Transplant; 2009 Mar; 7(1):58-61. PubMed ID: 19364315
[TBL] [Abstract][Full Text] [Related]
27. Novel treatment with rituximab of oropharyngeal posttransplant lymphoproliferative disorder after heart transplantation.
Kaczmarek I; Beiras-Fernandez A; Sadoni S; Bengel D; Deutsch MA; Meiser B; Reichart B
Exp Clin Transplant; 2005 Dec; 3(2):381-4. PubMed ID: 16417448
[TBL] [Abstract][Full Text] [Related]
28. Role of chemotherapy and rituximab for treatment of posttransplant lymphoproliferative disorder in solid organ transplantation.
Lee JJ; Lam MS; Rosenberg A
Ann Pharmacother; 2007 Oct; 41(10):1648-59. PubMed ID: 17848421
[TBL] [Abstract][Full Text] [Related]
29. Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
Gross TG; Bucuvalas JC; Park JR; Greiner TC; Hinrich SH; Kaufman SS; Langnas AN; McDonald RA; Ryckman FC; Shaw BW; Sudan DL; Lynch JC
J Clin Oncol; 2005 Sep; 23(27):6481-8. PubMed ID: 16170157
[TBL] [Abstract][Full Text] [Related]
30. Treatment and outcomes in classic Hodgkin lymphoma post-transplant lymphoproliferative disorder in children.
Twist CJ; Hiniker SM; Gratzinger D; Gutkin PM; Merriott DJ; Iagaru A; Link MP; Donaldson SS
Pediatr Blood Cancer; 2019 Aug; 66(8):e27803. PubMed ID: 31062898
[TBL] [Abstract][Full Text] [Related]
31. Evolution of PTLD following renal transplantation in a child.
Markert E; Siebolts U; Habbig S; Odenthal M; Dienes HP; Stippel DL; Hoppe B; Wickenhauser C
Pediatr Transplant; 2009 May; 13(3):379-83. PubMed ID: 19017284
[TBL] [Abstract][Full Text] [Related]
32. The emerging role of rituximab in organ transplantation.
Becker YT; Samaniego-Picota M; Sollinger HW
Transpl Int; 2006 Aug; 19(8):621-8. PubMed ID: 16827678
[TBL] [Abstract][Full Text] [Related]
33. Bone marrow necrosis complicating post-transplant lymphoproliferative disorder: resolution with rituximab.
Rossi D; Ramponi A; Franceschetti S; Stratta P; Gaidano G
Leuk Res; 2008 May; 32(5):829-34. PubMed ID: 18036657
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of an Epstein-Barr virus-associated B-cell lymphoproliferative disease in a child with acute lymphoblastic leukemia using an anti-CD20 monoclonal antibody.
Bernard F; Sarran N; Margueritte G; Barneon G; Astruc J
Med Pediatr Oncol; 2001 Feb; 36(2):329-31. PubMed ID: 11452947
[No Abstract] [Full Text] [Related]
35. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder presenting with skin involvement after CD34-selected autologous peripheral blood stem cell transplantation.
Takahashi S; Watanabe D; Miura K; Ozawa H; Tamada Y; Hara K; Matsumoto Y
Eur J Dermatol; 2007; 17(3):242-4. PubMed ID: 17478388
[TBL] [Abstract][Full Text] [Related]
36. Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines.
Parker A; Bowles K; Bradley JA; Emery V; Featherstone C; Gupte G; Marcus R; Parameshwar J; Ramsay A; Newstead C;
Br J Haematol; 2010 Jun; 149(5):693-705. PubMed ID: 20408848
[TBL] [Abstract][Full Text] [Related]
37. Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute.
Hou HA; Yao M; Tang JL; Chen YK; Ko BS; Huang SY; Tien HF; Chang HH; Lu MY; Lin TT; Lin KH; Hsiao CH; Lin CW; Chen YC
Bone Marrow Transplant; 2009 Feb; 43(4):315-21. PubMed ID: 18836488
[TBL] [Abstract][Full Text] [Related]
38. Successful prolonged rituximab treatment for post-transplant lymphoproliferative disorder following living donor liver transplantation in a child.
Hayashida M; Ogita K; Matsuura T; Takahashi Y; Nishimoto Y; Ohga S; Hara T; Soejima Y; Taketomi A; Maehara Y; Kohashi K; Tsuneyoshi M; Taguchi T
Pediatr Transplant; 2007 Sep; 11(6):671-5. PubMed ID: 17663692
[TBL] [Abstract][Full Text] [Related]
39. Treatment of post-transplant lymphoproliferative disorder with rituximab and radiation in a patient with second renal allograft.
Molnar I; Keung YK
Nephrol Dial Transplant; 2001 Oct; 16(10):2114-5. PubMed ID: 11572917
[No Abstract] [Full Text] [Related]
40. Prolonged hypogammaglobulinemia following rituximab treatment for post transplant Epstein-Barr virus-associated lymphoproliferative disease.
Imashuku S; Teramura T; Morimoto A; Naya M; Kuroda H
Bone Marrow Transplant; 2004 Jan; 33(1):129-30. PubMed ID: 14647260
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
